D'Orazio & Associates, Inc. Amgen Inc Transaction History

D'Orazio & Associates, Inc.

$619 Million
Q1 2024

A detailed history of D'Orazio & Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, D'Orazio & Associates, Inc. holds 3,068 shares of AMGN stock, worth $953,779. This represents 0.14% of its overall portfolio holdings.

Number of Shares

3,068

Previous 3,056 0.39%

Holding current value

$953,779

Previous $880,000 0.91%

% of portfolio

0.14%

Previous 0.16%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $3,226 - $3,894	12 Added 0.39%	3,068 $872,000
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $12,785 - $14,422	50 Added 1.66%	3,056 $880,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $137,093 - $170,205	627 Added 26.36%	3,006 $807,000
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $180,843 - $213,844	-844 Reduced 26.19%	2,379 $528,000
Q1 2023 Apr 21, 2023	SELL	$225.79 - $275.2 $234,821 - $286,208	-1,040 Reduced 24.4%	3,223 $779,000

Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $214,372 - $272,385	936 Added 28.13%	4,263 $0
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $78,336 - $88,349	-349 Reduced 9.49%	3,327 $750,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $201,409 - $224,134	873 Added 31.15%	3,676 $894,000
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $110,950 - $122,740	506 Added 22.03%	2,803 $678,000
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $19,490 - $22,304	-98 Reduced 4.09%	2,297 $517,000
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $87,455 - $102,464	412 Added 20.78%	2,395 $509,000
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $73,896 - $86,113	333 Added 20.18%	1,983 $493,000
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $25,965 - $30,920	120 Added 7.84%	1,650 $379,000
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $9,750 - $11,682	-56 Reduced 3.53%	1,530 $296,000
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $1,500 - $1,758	-9 Reduced 0.56%	1,586 $292,000
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $11,756 - $13,252	65 Added 4.25%	1,595 $303,000
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $8,471 - $9,900	50 Added 3.38%	1,530 $261,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $247,589 - $282,680	1,480	1,480 $276,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.

Account

D'Orazio & Associates, Inc. Amgen Inc Transaction History